tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
MCRB is currently covered by 5 analysts with an average price target of $135.3. This is a potential upside of $116.36 (614.36%) from yesterday's end of day stock price of $18.94.
Seres Therapeutics's activity chart (see below) currently has 44 price targets and 49 ratings on display. The stock rating distribution of MCRB is 71.43% BUY, 14.29% HOLD and 14.29% SELL.
Analysts average stock forecasts to be materialized ratio is 39% with an average time for these price targets to be met of 74.4 days.
Highest price target for MCRB is $15, Lowest price target is $6, average price target is $10.5.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 08-May-2025. First documented stock forecast 22-Oct-2015.
Currently out of the existing stock ratings of MCRB, 10 are a BUY (71.43%), 2 are a HOLD (14.29%), 2 are a SELL (14.29%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$6
$-13.44 (-69.14%)
$25
3 months 21 days ago
(08-May-2025)
1/5 (20%)
$-0.96 (-13.79%)
39
Sell
$15
$-4.44 (-22.84%)
$480
5 months 15 days ago
(14-Mar-2025)
3/3 (100%)
$1.2 (8.70%)
131
Buy
9 months 15 days ago
(14-Nov-2024)
0/3 (0%)
$101.2 (85.19%)
Sell
$140
10 months 5 days ago
(24-Oct-2024)
0/1 (0%)
$11.2 (8.70%)
Buy
$240
$220.56 (1134.57%)
$720
2 years 2 months 3 days ago
(26-Jun-2023)
4/8 (50%)
$132 (122.22%)
281
What is MCRB (Seres Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MCRB (Seres Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MCRB (Seres Therapeutics)?
Which analyst is the currently most bullish on MCRB (Seres Therapeutics)?
Which analyst is the currently most reserved on MCRB (Seres Therapeutics)?
